Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
622
Employees622
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
622
Employees622

AXGN Key Statistics

Market cap
3.34B
Market cap3.34B
Price-Earnings ratio
-85.99
Price-Earnings ratio-85.99
Dividend yield
—
Dividend yield—
Average volume
1.91M
Average volume1.91M
High today
$57.46
High today$57.46
Low today
$55.01
Low today$55.01
Open price
$55.80
Open price$55.80
Volume
1.38M
Volume1.38M
52 Week high
$59.72
52 Week high$59.72
52 Week low
$23.00
52 Week low$23.00

Stock Snapshot

With a market cap of 3.34B, Axogen(AXGN) trades at $55.50. The stock has a price-to-earnings ratio of -85.99.

On 2026-11-15, Axogen(AXGN) stock traded between a low of $55.01 and a high of $57.46. Shares are currently priced at $55.50, which is +0.9% above the low and -3.4% below the high.

Axogen(AXGN) shares are trading with a volume of 1.38M, against a daily average of 1.91M.

In the last year, Axogen(AXGN) shares hit a 52-week high of $59.72 and a 52-week low of $23.00.

In the last year, Axogen(AXGN) shares hit a 52-week high of $59.72 and a 52-week low of $23.00.

AXGN News

Simply Wall St 1d
Earnings Upgrades Could Be A Big Deal For Axogen Stock

Axogen recently presented at Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum in New York, sharing its latest progress in peripheral...

Earnings Upgrades Could Be A Big Deal For Axogen Stock
TipRanks 3d
AxoGen Earnings Call Highlights Growth and BioCircuit Momentum

AxoGen ((AXGN)) has held its Q3 earnings call. Read on for the main highlights of the call. AxoGen’s earnings call delivered a strongly positive message, led b...

Simply Wall St 3d
Arcutis Biotherapeutics And 2 Other Top Healthcare Stocks

Global healthcare is back in focus as inflation pressures and higher rates keep investors hunting for sectors where demand is less tied to the economic cycle. T...

Arcutis Biotherapeutics And 2 Other Top Healthcare Stocks

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

More AXGN News

Simply Wall St 6d
Axogen Raised Its 2026 Outlook, Is The Upside Already Priced In?

Axogen earnings and guidance spark fresh investor focus Axogen (AXGN) stock is back in the spotlight after third quarter results showed higher sales and net in...

Axogen Raised Its 2026 Outlook, Is The Upside Already Priced In?

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.